GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aveanna Healthcare Holdings AVAH · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.20

-0.38%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.43bn

FY2018FY2025

Net income

$225.0m

FY2018FY2025

Free cash flow

$114.8m

FY2018FY2025

Shareholders' equity

$194.5m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$2.43bn$2.02bn$1.90bn$1.79bn$1.68bn$1.50bn$1.38bn$1.25bn
Gross profit$805.2m$635.5m$595.4m$553.2m$542.4m$454.5m$419.3m$394.3m
Operating income$265.4m$156.2m$8.1m−$556.8m−$36.1m$31.2m$39.0m$39.0m
Net income$225.0m−$10.9m−$134.5m−$662.0m−$117.0m−$57.0m−$76.5m−$47.1m
Diluted earnings per share1.05-0.05-0.70-3.56-0.62-0.40-0.56-0.26

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$2.03bn$1.66bn$1.61bn$1.71bn$2.33bn$1.84bn$1.58bn$1.55bn
Cash and short-term investments$193.3m$84.3m$43.9m$19.2m$30.5m$137.3m$3.3m$8.0m
Total liabilities$1.83bn$1.79bn$1.74bn$1.72bn$1.70bn$1.58bn$1.31bn$1.21bn
Debt$1.49bn$1.47bn$1.46bn$1.44bn$1.25bn$1.19bn$52.4m$9.4m
Shareholders' equity$194.5m−$122.1m−$127.4m−$4.2m$638.0m$267.2m$270.9m$345.0m
Shares outstanding215m204m191m186m188m142m137m180m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations$122.2m$32.6m$22.7m−$48.4m−$11.3m$116.6m−$8.7m$21.6m
Capital spending−$7.4m−$6.3m−$6.1m−$12.0m−$15.9m−$15.2m−$16.6m−$19.6m
Free cash flow$114.8m$26.3m$16.6m−$60.4m−$27.3m$101.4m−$25.4m$2.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$670.5m$647.9m$662.5m$621.9m$589.6m$559.2m$519.9m$509.0m
Gross profit$218.5m$202.4m$210.6m$202.8m$210.8m$183.6m$171.7m$159.7m
Operating income$80.0m$75.9m$77.3m$52.4m$83.4m$51.9m$47.1m$34.2m
Net income$40.3m$41.7m$178.8m$14.1m$27.0m$5.2m$29.2m−$42.8m
Diluted earnings per share0.180.190.830.060.130.030.15-0.22
Cash from operations$80.0m$4.0m$49.0m$33.0m$51.0m−$8.0m$13.0m$29.0m
Capital spending−$1.0m−$4.0m−$5.0m−$2.0m−$1.0m−$2.0m−$1.0m−$2.0m
Free cash flow$79.0m$0$44.0m$31.0m$50.0m−$10.0m$12.0m$27.0m
Total assets$2.11bn$2.02bn$2.03bn$1.81bn$1.77bn$1.66bn$1.66bn$1.64bn
Cash and short-term investments$97.2m$189.3m$193.3m$145.9m$100.7m$71.5m$84.3m$78.5m
Debt$194.7m$1.48bn$1.49bn$1.29bn$1.27bn$1.27bn$1.28bn$1.28bn
Shareholders' equity$287.3m$240.1m$194.5m$9.9m−$11.3m−$98.7m−$122.1m−$155.0m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.1%31.4%31.4%30.9%32.3%30.4%
Operating margin10.3%7.7%0.5%-31.5%-3.2%2.1%
Net margin9.2%-0.5%-7.1%-37.0%-7.0%-3.8%
Return on equity115.7%9.0%105.6%15857.1%-18.3%-21.4%
Return on assets11.1%-0.7%-8.3%-38.7%-5.0%-3.1%
Free cash flow yield4.6%1.5%1.1%-1.5%0.2%7.0%
Revenue growth20.2%6.8%6.0%6.5%12.3%8.0%
Earnings growth-2159.1%-91.9%-79.7%465.6%105.2%-25.4%
Current ratio1.32x0.98x0.89x0.83x0.81x1.31x
Debt to equity7.65x-12.04x-11.45x-313.66x1.97x4.45x
Equity ratio9.6%-7.3%-7.9%-0.2%27.3%14.5%
Interest coverage1.79x1.00x0.06x-5.23x-0.77x0.38x
Buybacks as a share of market value-5.5%-6.8%-2.6%1.1%-32.4%-3.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.9%10.2%—
Operating income—53.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin32.3%31.8%31.7%—
Operating margin9.5%-1.6%-1.2%—
Net margin4.8%-7.2%-6.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings7.8-85.3-3.8-0.2-11.9
Price to sales0.80.50.30.10.9

Market value over time

30 Apr 2021 to 30 Oct 2026, in USD

$2.10bn$2.96bn

Share price return

Finished calendar years

20252024202320222021
Return104%72%230%-88%-46%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.